Cargando…
391. Outcomes of Empiric Antimicrobial Therapy in COVID-19 Positive Patients
BACKGROUND: The COVID-19 pandemic has revealed new challenges for antimicrobial stewardship. Optimal medical treatment is not completely understood at this time. The epidemiology and outcomes of bacterial co-infections are not well-established; however, empiric antibiotic (abx) use is anecdotally co...
Autores principales: | Medler, Corey J, Jakupovic, Lejla, Weinmann, Allison J, Kenney, Rachel, Davis, Susan L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777469/ http://dx.doi.org/10.1093/ofid/ofaa439.586 |
Ejemplares similares
-
182. Missed Opportunities to Discontinue Unnecessary Vancomycin During Pharmacist Therapeutic Monitoring
por: Medler, Corey J, et al.
Publicado: (2020) -
56. High Frequencies of Adverse Drug Events with Intravenous vs Oral High-Dose Trimethoprim-Sulfamethoxazole: An Opportunity for Antibiotic Stewardship
por: Vuong, Lisa, et al.
Publicado: (2021) -
98. Outcomes of Clinical Decision Support for Outpatient Management of Clostridioides difficile Infection
por: Wu, Tiffany, et al.
Publicado: (2021) -
The long-term sustainability of a respiratory culture nudge
por: Kaur, Supreet, et al.
Publicado: (2022) -
62. Secondary Prophylaxis in Clostridioides difficile Infections: a Closer Look at Outcomes
por: Rodriguez, Rubi, et al.
Publicado: (2021)